Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
GlyProVac ApS
APS
Active
CVR 39724758
Rørhatten 4, 5220
Odense SØ
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2018 · 7 years old
7 employees
Overvåg
Share
Denmark
/
Companies
/
Manufacture of pharmaceutical preparations
/
GlyProVac ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (1)
AB
Anders Boysen
Chief Executive Officer
Chief Executive Officer
2018
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (4)
KW
Kirsten Winther
Board of Directors
Board of Directors
2023
AR
Allan Rosetzsky
Board of Directors
Board of Directors
2022
AZ
Ann Zahle Andersen
Chairman
Chairman
2026
WA
Willem Adriaan de Jongh
Board of Directors
Board of Directors
2021
Former (2)
TP
Tommi Petteri Kainu
Chairman
Chairman
2023 – 2026
PS
Peter Smedegaard
Chairman
Chairman
2018 – 2019
Aktionærer
Pr. seneste årsrapport
Shareholder
Type
Ownership
Votes
Since
GlycoPharma Holding ApS
Company
33.33–49.99%
33.33–49.99%
2022
Rossi Finans ApS
Company
10–14.99%
10–14.99%
2023
Bente Kristiansen
Individual
10–14.99%
10–14.99%
2026
I/S Rødeledsvej
Company
5–9.99%
5–9.99%
2022
Uddannelses- og Forskningsstyrelsen
Company
10–14.99%
10–14.99%
2023
Niels Hermann Kristiansen
Individual
10–14.99%
10–14.99%
2023
AR CONSULT ApS
Company
5–9.99%
5–9.99%
2022
Marigold Innovation ApS
Company
5–9.99%
5–9.99%
2020
SYDDANSK INNOVATION ApS
Company
5–9.99%
5–9.99%
2020
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on GlyProVac ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network